Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children

J E Fergie1, K Purcell

  • 1Driscoll Children's Hospital, 3533 S. Alameda St., Corpus Christi, TX 78411, USA. fergiej@driscollchildrens.org

Abstract

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) infections increased significantly in children. CAMRSA isolates showed higher susceptibility to trimethoprim-sulfamethoxazole and clindamycin compared to hospital-acquired MRSA.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Antibiotic Resistance

Background:

  • Rising incidence of community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) infections observed between 1990 and 2000.
  • CAMRSA has become a significant concern in pediatric populations.

Purpose of the Study:

  • To determine the frequency of CAMRSA isolates in children.
  • To describe the clinical spectrum of CAMRSA infections in pediatric patients.
  • To compare antibiotic susceptibility of community-acquired versus nosocomial MRSA.

Main Methods:

  • Retrospective analysis of Staphylococcus aureus and MRSA infections from 1990-2000.
  • Utilized Vitek system culture data and Infection Control Committee records.
  • Reviewed medical records of infected children to identify risk factors and infection types.

Main Results:

  • MRSA identified in 147 children; CAMRSA cases increased from 7 to 53 between 1997-2000.
  • 60% of reviewed pediatric MRSA cases were community-acquired, often without identified risk factors.
  • CAMRSA isolates from children without risk factors demonstrated greater susceptibility to trimethoprim-sulfamethoxazole and clindamycin than nosocomial MRSA.

Conclusions:

  • CAMRSA is an emerging cause of common pediatric infections.
  • Initial antibiotic selection may need adjustment for critically ill children to ensure effective MRSA coverage.
  • Understanding susceptibility patterns is crucial for guiding empirical treatment decisions.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...